Shareholder Information

UK City Code on Takeovers and Mergers
Other exchanges and trading platforms
Number of AIM securities in issue
Significant shareholdings
Director shareholdings
Shares not in public hands
Restrictions in transfer of AIM Securities

UK City Code on Takeovers and Mergers

The Company is subject to the provisions of the City Code on Takeovers and Mergers.

Other exchanges and trading platforms

Trellus Health has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.

Number of AIM securities in issue

241,612,340 shares are issued, called up and fully paid. The Company holds no shares in treasury.
This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Significant shareholdings

Significant shareholders	No. of ordinary shares	% held
Icahn School of Medicine at Mount Sinai	40,384,897	17.9%
Marla Dubinsky	8,750,500	3.62%
Laurie Keefer	8,759,351	3.62%

Director Shareholdings

*Director*	*Number*	*Ordinary Shares* %
Marla Dubinsky	8,750,500	3.62%
Mike Salter	1,126,026	.47%

Shares not in public hands

Percentage of securities not in public hands: As at 13 March 2026 the percentage of AIM securities not in the public hands was 20.80%. The securities not in public hands include all substantial over 10% shareholders and the directors and senior management who are classed as persons discharging managerial responsibilities.

Restrictions in transfer of AIM Securities

There are no restrictions on the transfer of the Company’s ordinary shares.

Last updated: 13 March 2026